Lee, Danner & Bass’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.91M | Sell |
21,832
-122
| -0.6% | -$41.8K | 0.46% | 51 |
|
|
2026
Q1 | $7.72M | Buy |
21,954
+54
| +0.2% | +$19.3K | 0.49% | 50 |
|
|
2025
Q4 | $7.17M | Sell |
21,900
-454
| -2% | -$144K | 0.51% | 41 |
|
|
2025
Q3 | $6.31M | Sell |
22,354
-575
| -3% | -$167K | 0.46% | 47 |
|
|
2025
Q2 | $6.4M | Sell |
22,929
-80
| -0.3% | -$22.7K | 0.5% | 40 |
|
|
2025
Q1 | $7.17M | Sell |
23,009
-391
| -2% | -$115K | 0.58% | 36 |
|
|
2024
Q4 | $6.1M | Sell |
23,400
-48
| -0.2% | -$14.2K | 0.48% | 44 |
|
|
2024
Q3 | $7.55M | Buy |
23,448
+95
| +0.4% | +$31.1K | 0.53% | 37 |
|
|
2024
Q2 | $7.3M | Buy |
+23,353
| New | +$6.86M | 0.56% | 36 |
|
|
2023
Q4 | $6.72M | Sell |
23,323
-3,562
| -13% | -$971K | 0.58% | 42 |
|
|
2023
Q3 | $7.23M | Sell |
26,885
-1,475
| -5% | -$368K | 0.65% | 35 |
|
|
2023
Q2 | $6.3M | Hold |
28,360
| – | – | 0.54% | 39 |
|
|
2023
Q1 | $6.86M | Sell |
28,360
-538
| -2% | -$132K | 0.63% | 37 |
|
|
2022
Q4 | $7.59M | Sell |
28,898
-3,090
| -10% | -$828K | 0.72% | 34 |
|
|
2022
Q3 | $7.21M | Sell |
31,988
-1,097
| -3% | -$266K | 0.76% | 34 |
|
|
2022
Q2 | $8.05M | Sell |
33,085
-789
| -2% | -$193K | 0.81% | 34 |
|
|
2022
Q1 | $8.19M | Sell |
33,874
-289
| -0.8% | -$66.4K | 0.7% | 39 |
|
|
2021
Q4 | $7.69M | Sell |
34,163
-887
| -3% | -$187K | 0.66% | 39 |
|
|
2021
Q3 | $7.45M | Sell |
35,050
-483
| -1% | -$111K | 0.69% | 40 |
|
|
2021
Q2 | $8.66M | Sell |
35,533
-216
| -0.6% | -$53.1K | 0.78% | 32 |
|
|
2021
Q1 | $8.89M | Hold |
35,749
| – | – | 0.86% | 29 |
|
|
2020
Q4 | $8.22M | Buy |
35,749
+308
| +0.9% | +$71K | 0.88% | 28 |
|
|
2020
Q3 | $9.01M | Buy |
35,441
+285
| +0.8% | +$70.6K | 1.07% | 23 |
|
|
2020
Q2 | $8.29M | Sell |
35,156
-744
| -2% | -$170K | 1.06% | 24 |
|
|
2020
Q1 | $7.28M | Buy |
35,900
+1,625
| +5% | +$355K | 1.04% | 24 |
|
|
2019
Q4 | $8.26M | Sell |
34,275
-1,753
| -5% | -$386K | 0.86% | 32 |
|
|
2019
Q3 | $6.97M | Sell |
36,028
-125
| -0.3% | -$24K | 0.75% | 38 |
|
|
2019
Q2 | $6.66M | Sell |
36,153
-145
| -0.4% | -$26K | 0.7% | 42 |
|
|
2019
Q1 | $6.9M | Buy |
36,298
+513
| +1% | +$98K | 0.76% | 41 |
|
|
2018
Q4 | $6.97M | Buy |
35,785
+340
| +1% | +$66.3K | 0.82% | 35 |
|
|
2018
Q3 | $7.35M | Sell |
35,445
-306
| -0.9% | -$60.3K | 0.73% | 38 |
|
|
2018
Q2 | $6.6M | Sell |
35,751
-1,425
| -4% | -$252K | 0.7% | 40 |
|
|
2018
Q1 | $6.34M | Buy |
37,176
+3,652
| +11% | +$670K | 0.66% | 42 |
|
|
2017
Q4 | $5.83M | Buy |
33,524
+290
| +0.9% | +$51.3K | 0.59% | 47 |
|
|
2017
Q3 | $6.2M | Buy |
33,234
+91
| +0.3% | +$16.1K | 0.67% | 42 |
|
|
2017
Q2 | $5.71M | Buy |
33,143
+1,549
| +5% | +$252K | 0.64% | 43 |
|
|
2017
Q1 | $5.18M | Buy |
31,594
+19
| +0.1% | +$3.16K | 0.58% | 46 |
|
|
2016
Q4 | $4.62M | Buy |
31,575
+884
| +3% | +$133K | 0.54% | 48 |
|
|
2016
Q3 | $5.12M | Buy |
30,691
+2,805
| +10% | +$474K | 0.62% | 43 |
|
|
2016
Q2 | $4.24M | Buy |
27,886
+6,525
| +31% | +$1.01M | 0.51% | 49 |
|
|
2016
Q1 | $3.48M | Sell |
21,361
-300
| -1% | -$44.6K | 0.43% | 57 |
|
|
2015
Q4 | $3.52M | Sell |
21,661
-335
| -2% | -$52.7K | 0.46% | 57 |
|
|
2015
Q3 | $3.04M | Buy |
21,996
+888
| +4% | +$140K | 0.41% | 59 |
|
|
2015
Q2 | $3.24M | Buy |
21,108
+536
| +3% | +$85.9K | 0.39% | 59 |
|
|
2015
Q1 | $3.29M | Buy |
20,572
+675
| +3% | +$106K | 0.39% | 59 |
|
|
2014
Q4 | $3.17M | Buy |
19,897
+50
| +0.3% | +$7.79K | 0.38% | 55 |
|
|
2014
Q3 | $2.79M | Sell |
19,847
-1,595
| -7% | -$208K | 0.34% | 62 |
|
|
2014
Q2 | $2.54M | Buy |
21,442
+1,160
| +6% | +$134K | 0.31% | 64 |
|
|
2014
Q1 | $2.5M | Buy |
20,282
+6,063
| +43% | +$735K | 0.32% | 63 |
|
|
2013
Q4 | $1.62M | Hold |
14,219
| – | – | 0.22% | 76 |
|
|
2013
Q3 | $1.59M | Hold |
14,219
| – | – | 0.22% | 73 |
|
|
2013
Q2 | $1.4M | Buy |
+14,219
| New | +$1.48M | 0.2% | 80 |
|
Other funds holding AMGN
FFM
SP
Lee, Danner & Bass's AMGN Position: Q2 2026 in Review
Lee, Danner & Bass reduced its Amgen (AMGN) stake by 0.56% in Q2 2026, selling an estimated $41.8K and leaving 21,832 shares worth $7.91M. The position accounts for 0.46% of the portfolio, ranked #51.
Lee, Danner & Bass first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.01M in Q3 2020. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lee, Danner & Bass held 21,832 shares of Amgen worth $7.91M as of Q2 2026.
- Lee, Danner & Bass sold 122 Amgen shares in Q2 2026, an estimated $41.8K.
- Amgen made up 0.46% of Lee, Danner & Bass's portfolio in Q2 2026, its #51 holding.
- Lee, Danner & Bass first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Lee, Danner & Bass's Amgen position peaked at $9.01M in Q3 2020.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.